Breast Cancer Inpatients Undergoing Mastectomy from a Hospital in Guangzhou, China: A Retrospective Analysis 2004-2013

  • Lu, Jian-Jun (Department of medical affaires, the First Affiliated Hospital of Sun Yat-sen University) ;
  • Li, Heng-Ai (Department of medical affaires, the First Affiliated Hospital of Sun Yat-sen University) ;
  • Xiong, Ying (Department of medical affaires, the First Affiliated Hospital of Sun Yat-sen University)
  • 발행 : 2015.06.26


Background: To explore the hospitalizations of breast cancer patients undergoing mastectomy, and to provide a basis for management, clinical prevention and treatment. Materials and Methods: We conducted an investigation by means of the retrospective survey and the medical records retrieval system, and made out the data of patients suffered from breast cancer in a hospital in Guangzhou from 2004 to 2013, including age, medical payment methods, pathological type, treatment, treatment results, complications, hospitalization days, cost and so on. Results: The average age of the inpatients was 50.14 years old. The main histologic types were infiltrating duct carcinoma (88.06%). The main surgery was modified radical mastectomy (80.41%). The cure rate was 90.80% during the 10 years. The main medical payment method was self-paying (57.28%). The average hospital stay was 13.51 days, and average hospitalization cost was RMB 23,083.66 yuan, proportion of drug fees up to 39.70%. Postoperative complication rate was 0.79%. The self-paying group was with the highest proportion of drug fees (P<0.05), while the free medical service group was with the longest hospitalization days (P<0.05). Conclusions: The payment methods significantly affected the proportion of drug fees and hospitalization days. The therapeutic effect was satisfactory with less complications and reasonable proportion of drug fees in our hospital.


Breast cancer;hospital-based;surgery;mastectomy;hospitalization cost;payment methods


  1. Vithana PC, Ariyaratne M, Jayawardana P (2015). Effectiveness of an educational intervention among public health midwives on breast cancer early detection in the district of Gampaha, Sri Lanka. Asian Pac J Cancer Prev, 16, 227-32.
  2. Shankar A, Rath G, Roy S, et al (2015). Level of awareness of cervical and breast cancer risk factors and safe practices among college teachers of different states in India: Do awareness programmes have an impact on adoption of safe practices? Asian Pac J Cancer Prev, 16, 927-32.
  3. Ramadas A, Qureshi AM, Dominic NA, et al (2015) Sociodemography and medical history as predictors of healthrelated quality of life of breast cancer survivors. Asian Pac J Cancer Prev, 16, 1479-85.
  4. Siegel RJ, Ma Z, Zou A, Jemal (2014). Cancer statistics, 2014. Ca Cancer J Clin, 64, 9-29.
  5. Song QK, Li J, Huang R, et al (2014). Age of diagnosis of breast cancer in china: almost 10 years earlier than in the United States and the European union. Asian Pac J Cancer Prev, 15, 10021-5.
  6. Beckmann MW, Lux MP (2013). Health economics in breast cancer. Breast care, 8:5-6.
  7. Fiszer C, Dolbeault S, Sultan S, Bredart A (2014). Prevalence, intensity, and predictors of the supportive care needs of women diagnosed with breast cancer: a systematic review. Psycho Oncol, 23, 361-74.
  8. Edwards BK, Noone AM, Mariotto AB, et al (2014). Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer, 120, 1290-314.
  9. Medina-Franco H, Rojas-Garcia P, Suarez-Bobadilla YL, Sanchez-Ramon A (2013). Factors associated with breast symmetry after breast conserving surgery for cancer. Rev Invest Clin, 65, 379-83.
  10. Katz SJ, Hawley ST (2007). From policy to patients and back: surgical treatment decision making for patients with breast cancer. Health Affairs, 26, 761-9.
  11. Hawley ST, Griggs JJ, Hamilton AS, et al (2009). Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients. J National Cancer Inst, 101, 1337-47.
  12. Gnerlich J, Jeffe DB, Deshpande AD, et al (2007). Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data. Ann Surgical Oncol, 14, 2187-94..
  13. Morrow M, Jagsi R, Alderman AK, et al (2009). Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. J Am Med Assoc, 302, 1551-6.
  14. Bafford AC, Burstein HJ, Barkley CR, et al (2009). Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival. Breast Cancer Res Treat, 115, 7-12.
  15. Gartner R, Jensen MB, Nielsen J, et al (2009). Prevalence of and factors associated with persistent pain following breast cancer surgery. J Am Med Assoc, 302, 1985-92.
  16. Kim J, Choi WJ, Jeong SH (2013). The effects of physical activity on breast cancer survivors after diagnosis. J Cancer Prev, 18, 193-200.
  17. Chung C, Lee S, Hwang S, Park E (2013). Systematic review of exercise effects on health outcomes in women with breast cancer. Asian Nurs Res, 7, 149-59.
  18. Comsa D, Barnett E, Le K, et al (2014). Introduction of moderate deep inspiration breath hold for radiation therapy of left breast: Initial experience of a regional cancer center. Practical radiation Oncol, 4, 298-305.
  19. Giuliano AE, K. K. Hunt, K. V. Ballman, et al (2011). Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. J Am Med Assoc, 305, 569-75.
  20. Murthy V, Ballehaninna UK, Chamberlain RS (2012). Unanswered questions about the role of axillary dissection in women with invasive breast cancer and sentinel node metastasis. Clinical Breast Cancer, 12, 305-7.
  21. Davidson A, Chia S, Olson R, et al (2013). Stage, treatment and outcomes for patients with breast cancer in British Columbia in 2002: a population-based cohort study. CMAJ Open, 1, 134-41.
  22. Reinisch M, von Minckwitz G, Harbeck N, et al (2013). Side effects of standard adjuvant and neoadjuvant chemotherapy regimens according to age groups in primary breast cancer. Breast Care, 8, 60-6.
  23. Vahdat LT, Rugo HS, Perez EA (2013). New developments in metastatic breast cancer: general discussion. Clinical Advanc Hematol Oncol, 11, 16-7.